Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$22,472,961
+$1,987,361 QoQ
Shares Held
89,306
-5.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#573
of 4,152 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Banque Cantonale Vaudoise holds $123,482,590 across 10 Drug Manufacturers - General names. ABBV ranks #3 (18.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
21,866 | $26,226,738 | |
| 2 | JNJ |
Johnson & Johnson
|
90,804 | $23,061,491 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
89,306 | $22,472,961 | |
| 4 | MRK |
Merck & Co., Inc.
|
105,147 | $13,511,389 | |
| 5 | AZN |
Astrazeneca PLC
|
60,462 | $11,464,804 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
63,781 | $8,058,091 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
136,299 | $7,853,548 | |
| 8 | PFE |
Pfizer Inc
|
286,435 | $6,897,354 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,472,961 | 89,306 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $20,485,600 | 94,191 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $21,401,515 | 93,665 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $17,435,656 | 75,303 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $14,217,749 | 76,596 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $14,555,144 | 69,469 | Shares | Sole | 2025-05-08 | |
| 2024-09-30 | $9,559,611 | 48,408 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $7,505,371 | 43,758 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $9,513,631 | 52,244 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $6,837,585 | 44,122 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $8,137,929 | 54,595 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $7,715,986 | 57,270 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $7,965,471 | 49,981 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $8,051,895 | 49,823 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $8,072,999 | 60,152 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $10,164,922 | 66,368 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $9,586,050 | 59,133 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $7,374,696 | 54,466 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,961,390 | 64,535 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $4,300,144 | 38,176 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $6,498,611 | 60,050 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $7,955,780 | 74,249 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $6,757,042 | 77,144 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $6,734,166 | 68,590 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $4,063,365 | 53,332 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||